Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
International Journal of Colorectal Disease|November 14, 2018
Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetesJetty A Overbeek, Josephina G Kuiper, Amber A W A van der Heijden, et al.Cancer Treatment Reviews|April 6, 2021
High-dose administration of tyrosine kinase inhibitors to improve clinical benefit: A systematic reviewSophie L Gerritse, Jorien B E Janssen, Mariette Labots, et al.Journal of Proteomics|April 19, 2015
Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomicsJohannes C van der Mijn, Mariette Labots, Sander R Piersma, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2018
Phase I Dose-Escalation Study of Once Weekly or Once Every Two Weeks Administration of High-Dose Sunitinib in Patients With Refractory Solid TumorsMaria Rovithi, Sophie L Gerritse, Richard J Honeywell, et al.Journal of Proteomics|April 6, 2015
Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell linesSander R Piersma, Jaco C Knol, Inge de Reus, et al.Experimental & Molecular Medicine|December 17, 2016
Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancerMariette Labots, Kristy J Gotink, Henk Dekker, et al.Journal for Immunotherapy of Cancer|May 13, 2026
Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?Marije A Strikwerda, Lotte L Hoeijmakers, Sophie P G R Veenstra, et al.ESC Heart Failure|February 19, 2026
Immune Checkpoint Inhibitor Myocarditis: When Profound Troponin Elevation Diverges From Unremarkable ImagingRoel S Driessen, P Stefan Biesbroek, Philippe J van Rosendael, et al.Cancers|December 23, 2022
High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid TumorsSophie L Gerritse, Mariette Labots, Rob Ter Heine, et al.Cancer Chemotherapy and Pharmacology|June 20, 2020
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumorsMats Någård, Mei-Lin Ah-See, Karen So, et al.Pageof 6